Walgreens
FDA Approves ADAPALENE — Walgreens
Walgreens received FDA approval on June 2 for a generic topical acne treatment containing Adapalene, a move expected to intensify competition and pric...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Amgen,
FDA Approves PROLIA — Amgen, Inc
Amgen’s (NASDAQ: AMGN) approval of the subcutaneous DENOSUMAB formulation shows the biotech giant intends to leverage the format’s improved dosing con...
QUAGEN
FDA Approves VALPROIC ACID — QUAGEN PHARMACEUTICALS LLC
# FDA Approves Quagen Pharmaceuticals' Generic Valproic Acid Oral Formulation Quagen Pharmaceuticals LLC received FDA approval for its generic valpro...
B.
FDA Approves CEFEPIME HYDROCHLORIDE AND DEXTROSE — B. Braun Medical Inc.
B. Braun Medical Inc. earned FDA approval today for Cefepime Hydrochloride and Dextrose Intravenous injection, a strategic addition to its hospital po...
ONESOURCE
FDA Approves Unknown Drug — ONESOURCE SPECIALTY
ONESOURCE SPECIALTY received FDA approval for its ANDA, marking a strategic entry or expansion into the generic market that is anticipated to generate...
TEVA
FDA Approves Unknown Drug — TEVA
# FDA Approves Generic Drug for Teva Pharmaceutical Industries Teva Pharmaceutical Industries received FDA approval for a generic drug application (A...
Knoa
FDA Approves OXYCONTIN — Knoa Pharma LLC
# FDA Approves OxyContin Generic Formulation for Knoa Pharma Knoa Pharma LLC received FDA approval for its generic oxycodone hydrochloride oral formu...
Actavis
FDA Approves MATZIM LA — Actavis Pharma, Inc.
# FDA Approves Actavis Pharma's Generic Diltiazem Extended-Release Formulation Actavis Pharma, Inc. received FDA approval for MATZIM LA (diltiazem hy...
Hikma
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Hikma Pharmaceuticals USA Inc.
Hikma Pharmaceuticals USA Inc. announced the receipt of FDA approval for its Abbreviated New Drug Application (ANDA040881) for hydrocodone bitartrate ...
Accord
FDA Approves FINASTERIDE — Accord Healthcare, Inc.
Accord Healthcare, Inc. received approval from the U.S. FDA for its Abbreviated New Drug Application (ANDA) 090121, providing a generic alternative to...
Hikma
FDA Approves VALPROATE SODIUM — Hikma Pharmaceuticals USA Inc.
Hikma Pharmaceuticals USA Inc. received FDA approval for its intravenous valproate sodium generic, positioning the manufacturer to capitalize on the f...
INGENUS
FDA Approves Unknown Drug — INGENUS PHARMS NJ
Ingenus Pharma has received FDA approval for its Abbreviated New Drug Application (ANDA), securing the necessary regulatory clearance to advance the p...
AIPING
FDA Approves Unknown Drug — AIPING PHARM INC
Aiping Pharm Inc received FDA approval for ANDA 078499, a regulatory milestone that enhances the company's market position and signals a potential exp...
TORRENT
FDA Approves Unknown Drug — TORRENT
TORRENT Pharmaceuticals received FDA approval on December 30, 2009, for ANDA090014; this regulatory milestone is anticipated to bolster the company's ...
H2-Pharma
FDA Approves ZYPREXA RELPREVV — H2-Pharma LLC
# FDA Approves H2-Pharma's ZYPREXA RELPREVV Long-Acting Injectable Formulation H2-Pharma LLC received FDA approval for ZYPREXA RELPREVV (olanzapine p...
GENUS
FDA Approves Unknown Drug — GENUS
Following the FDA’s approval of the generic version of the branded drug listed by ANDA077471, GENUS has secured immediate entry into the highly compet...
Ascend
FDA Approves METHADONE HYDROCHLORIDE — Ascend Laboratories, LLC
Ascend Laboratories, LLC secured FDA approval for its generic Methadone Hydrochloride product, a move expected to bolster the company's footprint in t...
Hospira,
FDA Approves HEPARIN SODIUM — Hospira, Inc.
Hospira, Inc. received approval from the FDA for its generic Heparin Sodium injection, a strategic move likely to deepen the company's share in the ac...
Aurobindo
FDA Approves CLINDAMYCIN HYDROCHLORIDE — Aurobindo Pharma Limited
Securities and Exchange: Aurobindo Pharma Limited announced the approval of its Abbreviated New Drug Application (ANDA065442) for generic clindamycin ...
EPIC
FDA Approves Unknown Drug — EPIC PHARMA LLC
EPIC Pharma received FDA approval for Abbreviated New Drug Application ANDA090895, which positions the company to enter the generic market, potentiall...